CapsoVision, Inc.
CV
NASDAQ·Healthcare·Medical - Devices·Mkt cap $299.3M
$5.99
▲ +0.34%
P/E
-5.45
Mkt Cap
$299.3M
52-Wk Range
$3.43–$15.37
52-Week Range
$3.43 - $15.37
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Up 64.6% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
5 reasons
- Proprietary miniaturized camera and capsule technology with superior visualization
- AI-powered image analysis platform for enhanced diagnostic accuracy and efficiency
- Non-invasive, sedation-free alternative to traditional endoscopy procedures
- Comprehensive GI tract visualization capabilities across multiple anatomical regions
- Established clinical evidence and regulatory clearances (FDA 510(k) approvals)
Bear Case
1 risk
- Low volatility (beta -2.5).
Growth
Stable outlook
Rising demand for minimally invasive diagnostic procedures and patient comfort
Value
Deep value opportunity - significant discount to sector peers
Momentum
Weak
-14.7% over 3m
Quality
Strong
Below average quality
Dividend
None
No dividend
Smart-money signal
Who's buying CV right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Recent earnings results
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Nov 12, 2026
AUG 13, 2026
Reported EPS of -$0.15 vs -$0.13 consensus (-15.4% surprise). Revenue of $3.6M vs $3.8M expected (-4.5%).
EPS surprise · last 4Q
0 of 1 beats
Estimate
Actual
Q3 26
-15.4%
Revenue trend · last 8Q
—
—
+12%
+17%
+42%
+38%
+0%
+10%
Q1 24
Q2 24
Q1 25
Q2 25
Q3 25
Q4 25
Q1 26
Q2 26
$2.5M
$2.8M
$2.8M
$3.3M
$3.5M
$3.9M
$2.8M
$3.6M
Margins · last 8Q
Gross
51.4%
Operating
2.7%
Profit
-205.3%
Wall Street consensus
1 analyst · 100% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
100%
Hold
0%
Sell
0%
Median Price Target
—
Latest: Benchmark · Mar 27, 2026
vs Industry
How CV stacks vs Medical - Devices
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.
Related